Mushroom antioxidant eases period pain in small trial

An antioxidant called L-ergothioneine, found in certain mushrooms, reduced period pain in a small study of 40 women. Participants took a daily 120-milligram supplement over three menstrual cycles, reporting lower pain scores compared to a placebo group. The findings suggest it targets oxidative stress in uterine cells.

Researchers led by Guohua Xiao at Gene III Biotechnology Co. in Nanjing, China, tested L-ergothioneine on women aged 18 to 30 with primary dysmenorrhea, a common cause of menstrual pain not linked to conditions like endometriosis. None had used painkillers or other treatments in the prior month. Half received 120 milligrams of the supplement daily for three cycles; the rest got a placebo. Initial pain scores averaged 4.8 out of 10, dropping to 4.1, 3.6 and 2.3 for the supplement group, with no notable change in the placebo group, according to a preprint on medRxiv (DOI: 10.64898/2026.03.26.26349375). No side effects were reported in either group. Xiao explained that L-ergothioneine accumulates in cells over time, potentially neutralizing free radicals in uterine tissue before inflammation escalates. “Instead of treating the symptom acutely when the pain is already severe, EGT acts as a nutritional foundational support, potentially reducing the reliance on strong medications,” Xiao said. The study found no difference in systemic inflammation levels between groups, supporting a localized antioxidant effect, Xiao added. Andrea Maier at the University of Melbourne called the mechanism biologically plausible but urged a larger trial for confirmation. Xiao's team plans a multi-center study to assess safety and efficacy further. Long-term painkiller use like ibuprofen carries risks including heart issues and kidney problems, unlike this supplement, which the kidneys excrete once saturated.

Related Articles

Scientific illustration depicting parathyroid hormone strengthening mouse vertebral endplates to repel pain nerves, reducing chronic low back pain in spinal degeneration models.
Image generated by AI

Study links parathyroid hormone to reduced chronic low back pain in mice by limiting abnormal nerve growth

Reported by AI Image generated by AI Fact checked

A study published in the journal *Bone Research* reports that parathyroid hormone (PTH) reduced pain-related behaviors in mouse models of spinal degeneration, apparently by strengthening vertebral endplates and triggering bone-cell signals that repel pain-sensing nerve fibers. The work was led by Dr. Janet L. Crane of Johns Hopkins University School of Medicine.

Duke University researchers report that boosting the transfer of healthy mitochondria from support cells to sensory neurons reduced pain-like behaviors in mouse models of diabetic and chemotherapy-related peripheral neuropathy, an approach they say could address a root driver of nerve pain rather than simply blocking pain signals.

Reported by AI

Researchers at Tokyo University of Science have discovered that combining common plant compounds from mint, eucalyptus, and chili peppers dramatically enhances their anti-inflammatory effects in immune cells. Certain pairings amplified the response several hundred-fold compared to individual use. The findings, published in the journal Nutrients, suggest potential for new dietary approaches to combat chronic inflammation.

Women with vitamin D deficiency face significantly more pain and greater opioid use following breast cancer surgery, according to new research. The study found deficient patients were three times more likely to experience moderate to severe discomfort in the first day after mastectomy.

Reported by AI

Researchers at Shandong University have modified the probiotic bacterium Escherichia coli Nissle 1917 to produce the anticancer drug Romidepsin directly in tumors. In mouse models of breast cancer, the engineered bacteria accumulated in tumors and released the drug. The findings were published on March 17 in PLOS Biology.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline